These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 18974063)

  • 21. -765 G→C and -1195 A→G promoter variants of the cyclooxygenase-2 gene decrease the risk for preeclampsia.
    Gurdol F; Cakmakoglu B; Dasdemir S; Isbilen E; Bekpinar S; Isbir T
    Genet Test Mol Biomarkers; 2012 May; 16(5):435-8. PubMed ID: 22224631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ICAM gene cluster SNPs and prostate cancer risk in African Americans.
    Chen H; Hernandez W; Shriver MD; Ahaghotu CA; Kittles RA
    Hum Genet; 2006 Aug; 120(1):69-76. PubMed ID: 16733712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of genetic polymorphisms in the interleukin-10 promoter with risk of prostate cancer in Chinese.
    Liu J; Song B; Bai X; Liu W; Li Z; Wang J; Zheng Y; Wang Z
    BMC Cancer; 2010 Aug; 10():456. PubMed ID: 20735825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MSR1 variants and the risks of prostate cancer and benign prostatic hyperplasia: a population-based study in China.
    Hsing AW; Sakoda LC; Chen J; Chokkalingam AP; Sesterhenn I; Gao YT; Xu J; Zheng SL
    Carcinogenesis; 2007 Dec; 28(12):2530-6. PubMed ID: 17768178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymorphisms in inflammatory genes, plasma antioxidants, and prostate cancer risk.
    Zhang J; Dhakal IB; Lang NP; Kadlubar FF
    Cancer Causes Control; 2010 Sep; 21(9):1437-44. PubMed ID: 20431935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclooxygenase-2 genetic polymorphism and stroke subtypes in Chinese.
    Chen GZ; Shan XY; Cheng GP; Tao HM
    J Mol Neurosci; 2013 Oct; 51(2):467-73. PubMed ID: 23907768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Genetic polymorphisms in the promoter region of cyclooxygenase-2 and their association with risk of gastric cancer].
    Zhang XM; Miao XP; Tan W; Sun T; Guo YL; Zhao D; Lin DX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Apr; 28(2):119-23. PubMed ID: 16733888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphic variants in PTGS2 and prostate cancer risk: results from two large nested case-control studies.
    Danforth KN; Hayes RB; Rodriguez C; Yu K; Sakoda LC; Huang WY; Chen BE; Chen J; Andriole GL; Calle EE; Jacobs EJ; Chu LW; Figueroa JD; Yeager M; Platz EA; Michaud DS; Chanock SJ; Thun MJ; Hsing AW
    Carcinogenesis; 2008 Mar; 29(3):568-72. PubMed ID: 17999989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphisms of Estrogen Metabolism-Related Genes and Prostate Cancer Risk in Two Populations of African Ancestry.
    Brureau L; Moningo D; Emeville E; Ferdinand S; Punga A; Lufuma S; Blanchet P; Romana M; Multigner L
    PLoS One; 2016; 11(4):e0153609. PubMed ID: 27074016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterizing genetic risk at known prostate cancer susceptibility loci in African Americans.
    Haiman CA; Chen GK; Blot WJ; Strom SS; Berndt SI; Kittles RA; Rybicki BA; Isaacs WB; Ingles SA; Stanford JL; Diver WR; Witte JS; Chanock SJ; Kolb S; Signorello LB; Yamamura Y; Neslund-Dudas C; Thun MJ; Murphy A; Casey G; Sheng X; Wan P; Pooler LC; Monroe KR; Waters KM; Le Marchand L; Kolonel LN; Stram DO; Henderson BE
    PLoS Genet; 2011 May; 7(5):e1001387. PubMed ID: 21637779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Association between single nucleotide polymorphisms in the promoter of cyclooxygenase COX-2 gene and hereditary susceptibility to pancreatic cancer].
    Xu DK; Zhang XM; Zhao P; Cai JC; Zhao D; Tan W; Guo YL; Lin DX
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1961-5. PubMed ID: 19062735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Custom Genotyping Array Reveals Population-Level Heterogeneity for the Genetic Risks of Prostate Cancer and Other Cancers in Africa.
    Harlemon M; Ajayi O; Kachambwa P; Kim MS; Simonti CN; Quiver MH; Petersen DC; Mittal A; Fernandez PW; Hsing AW; Baichoo S; Agalliu I; Jalloh M; Gueye SM; Snyper NYF; Adusei B; Mensah JE; Abrahams AOD; Adebiyi AO; Orunmuyi AT; Aisuodionoe-Shadrach OI; Nwegbu MM; Joffe M; Chen WC; Irusen H; Neugut AI; Quintana Y; Seutloali M; Fadipe MB; Warren C; Woehrmann MH; Zhang P; Ongaco CM; Mawhinney M; McBride J; Andrews CV; Adams M; Pugh E; Rebbeck TR; Petersen LN; Lachance J
    Cancer Res; 2020 Jul; 80(13):2956-2966. PubMed ID: 32393663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EphB2 SNPs and sporadic prostate cancer risk in African American men.
    Robbins CM; Hooker S; Kittles RA; Carpten JD
    PLoS One; 2011; 6(5):e19494. PubMed ID: 21603658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Arachidonate lipoxygenase (ALOX) and cyclooxygenase (COX) polymorphisms and colon cancer risk.
    Goodman JE; Bowman ED; Chanock SJ; Alberg AJ; Harris CC
    Carcinogenesis; 2004 Dec; 25(12):2467-72. PubMed ID: 15308583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic association of cyclooxygenase-2 gene polymorphisms with Parkinson's disease susceptibility in Chinese Han population.
    Dai Y; Wu Y; Li Y
    Int J Clin Exp Pathol; 2015; 8(10):13495-9. PubMed ID: 26722563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSA.
    Severi G; Hayes VM; Neufing P; Padilla EJ; Tilley WD; Eggleton SA; Morris HA; English DR; Southey MC; Hopper JL; Sutherland RL; Boyle P; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1142-7. PubMed ID: 16775173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancer.
    Wang V; Geybels MS; Jordahl KM; Gerke T; Hamid A; Penney KL; Markt SC; Freedman M; Pomerantz M; Lee GM; Rana H; Börnigen D; Rebbeck TR; Huttenhower C; Eeles RA; Stanford JL; Consortium P; Berndt SI; Claessens F; Sørensen KD; Park JY; Vega A; Usmani N; Mucci L; Sweeney CJ
    Prostate; 2021 Jul; 81(10):683-693. PubMed ID: 33956343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-1 receptor antagonist haplotype associated with prostate cancer risk.
    Lindmark F; Zheng SL; Wiklund F; Bälter KA; Sun J; Chang B; Hedelin M; Clark J; Johansson JE; Meyers DA; Adami HO; Isaacs W; Grönberg H; Xu J
    Br J Cancer; 2005 Aug; 93(4):493-7. PubMed ID: 16106254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Relationship between single nucleotide polymorphisms in the promoter of COX-2 gene and hereditariness to NAFLD].
    Cao MB; Yang YX; Dong L
    Zhonghua Gan Zang Bing Za Zhi; 2010 Oct; 18(10):773-7. PubMed ID: 21059296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitor kappaB-alpha haplotype GTC is associated with susceptibility to acute respiratory distress syndrome in Caucasians.
    Zhai R; Zhou W; Gong MN; Thompson BT; Su L; Yu C; Kraft P; Christiani DC
    Crit Care Med; 2007 Mar; 35(3):893-8. PubMed ID: 17235259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.